TEST-BRAF-TISSUE-MULTI
TEST-BRAF-TISSUE-MULTI
The reagent kit is designed for examination of patients diagnosed with melanoma, papillary thyroid cancer, ovarian, colorectal and prostate cancer in order to determine an effective strategy for targeted therapy.
Advantages
- Detects 7 BRAF gene mutations. High specificity and sencitivity of the test. Reduced contamination risk due to uracil-DNA-glycosylase (UDG) and 2'-deoxyuridine-5'-triphosphate (dUTP) included in the reaction mixture.
Detection method
PCR-RT
Analysis type
Qualitative
Количество мутаций
7
Samples
Formalin-fixed paraffin-embedded tissue (FFPE blocks)
Analytical sensitivity
10 copies of the BRAF gene in 1 µl of DNA solution
Sensirtivity
100 % (with 95% confidence interval)
Specificity
100 % (with 95% confidence interval)
Time per 1 analysis
60 min.
Number of reactions
28
Equipment
CFX96, DTprime, Rotor-Gene Q, QuantStudio 5
Format
Multiplex
Transportation and
Storage conditions
Storage conditions
+2 °C…+8 °C up to 90 days
+15 °C…+25 °C up to 5 days
+15 °C…+25 °C up to 5 days
Designed by